Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06124898 · ClinicalTrials.gov registry record · NA
Multi-Component Breath Alcohol Intervention
A NA study of Alcohol Drinking and Alcohol Use, sponsored by Northeastern University.
- Active
- Registry status
- NA
- Development phase
- 115
- Enrollment target
- 1
- Study location
NCT06124898: Active NA study of Alcohol Drinking and Alcohol Use, sponsored by Northeastern University.
NCT06124898 is a NA study of Alcohol Drinking and Alcohol Use that is active but no longer recruiting, run by Northeastern University. The registered enrollment target is 115 participants, below the 629-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06124898, a NA study of Alcohol Drinking and Alcohol Use, is active but no longer recruiting, sponsored by Northeastern University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
- 1
- Study location
Study Summary
This is the first stage of a three-stage, NIH-funded study to develop and test initially a multi-modal intervention concerning blood/breath alcohol concentration for young adults. The multimodal intervention will be made up of brief telehealth counseling and psychoeducation and use of three mobile technologies to facilitate moderate drinking. In the first stage of the study, we will conduct formative research to obtain input from the study population, test initially the telehealth version of the brief counseling and psychoeducation and to develop a simple, "low tech" approach to coaching participants to use the three mobile technologies in typical drinking situations. Participation will last approximately one month.
Primary Outcome
Percentage of reported drinking days on which one reports that moderate drinking technology use has occurred
Conditions Studied
Interventions
- DEVICE Alcohol-related mobile health technologies
- BEHAVIORAL Motivational interview and psychoeducation on blood/breath alcohol concentration
- BEHAVIORAL Lower tech facilitation
- DEVICE Higher tech facilitation
- BEHAVIORAL Attention control psychoeducation
Study Locations (1)
Massachusetts
- EDGE Lab - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2023-11-09 |
| Est. Completion | 2025-09-01 |
| Phase | NA |
What the registry record for NCT06124898 still lists
NCT06124898 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 629-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (82% lower).
The record links to 3 conditions, with Alcohol Drinking appearing as the primary indexed condition, and to 5 interventions - of which Alcohol-related mobile health technologies is the first listed.
NCT06124898 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06124898 about?
NCT06124898 is a clinical study titled "Multi-Component Breath Alcohol Intervention". This is the first stage of a three-stage, NIH-funded study to develop and test initially a multi-modal intervention concerning blood/breath alcohol concentration for young adults. The multimodal intervention will be made up of brief telehealth counseling and psychoeducation and use of three mobile t...
What is the current status of trial NCT06124898?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 115 participants. The study started on 2023-11-09. Estimated completion is 2025-09-01.
What conditions does trial NCT06124898 study?
This clinical trial studies the following conditions: Alcohol Drinking, Alcohol Use, Drinking Behavior.
What interventions are being tested in trial NCT06124898?
The interventions under investigation include: Alcohol-related mobile health technologies (DEVICE), Motivational interview and psychoeducation on blood/breath alcohol concentration (BEHAVIORAL), Lower tech facilitation (BEHAVIORAL), Higher tech facilitation (DEVICE), Attention control psychoeducation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06124898?
This trial is sponsored by Northeastern University, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06124898 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Drinking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06124898's enrollment target sits among peer trials
115 54th of 85 higher than 31 of 85 other Alcohol Drinking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Drinking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Alcohol and "Heat of the Moment" Sexual Decision Making
RECRUITING · NA
-
Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
-
Multi-Component Breath Alcohol Intervention Phase 3
RECRUITING · NA
-
Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults
RECRUITING · NA
-
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI